DoximityDOCS +1.71%82 EBIT per Share is $1.08 as of Mar. 2026. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.17 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 532 Healthcare Providers & Services companies, Doximity ranks better than 65.79% on this metric.
Doximity's EBIT per Share for the
three
months ended in Mar. 2026 was $0.13.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $1.08.
During the past 12 months, the average EBIT per Share Growth Rate of Doximity was -5.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 22.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 28.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Doximity's EBIT per Share or its related term are showing as below:
DOCS'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 22.6 Med: 40.8 Max: 145.8
Current: 22.6
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Doximity was 145.80% per year. The lowest was 22.60% per year. And the median was 40.80% per year.
DOCS's 3-Year EBIT Growth Rate is ranked better than 65.79% of 532
companies
in the Healthcare Providers & Services industry
Industry Median: 11.75
vs DOCS: 22.60
Doximity's EBIT for the
three
months ended in Mar. 2026 was $24.8 Mil.
Doximity (NYSE:DOCS) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Doximity EBIT per Share Related Terms
Doximity EBIT per Share Historical Data
* Premium members only.
The historical data trend for Doximity's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doximity (DOCS) has a EBIT per Share of $1.08 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Doximity and its competitors. According to the industry distribution chart, Doximity ranks #182 out of 532 companies in the Healthcare Providers & Services industry, placing it in the top 34.2%.
Is Doximity's EBIT per Share too high?
Doximity's current EBIT per Share is $1.08. The Healthcare Providers & Services industry median EBIT per Share is 11.75. Doximity's value of $1.08 is 90.8% below this industry median. Based on the distribution chart, Doximity ranks #182 out of 532 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's EBIT per Share compare to WAY and TXG?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #182 out of 532 companies for EBIT per Share. This puts Doximity in the upper half of its industry. The industry median EBIT per Share is 11.75. Doximity's value of $1.08 is 90.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.75, based on 532 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current EBIT per Share of $1.08 is 90.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current EBIT per Share is $1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.17, compared to a current price of $20.83 — trading 57.6% below its estimated fair value. The current EBIT per Share is $1.08 and 90.8% below the Healthcare Providers & Services industry median of 11.75. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Doximity (DOCS), the current EBIT per Share is $1.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $20.83 is trading 57.6% below its estimated GF Value™ of $49.17.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
EBIT per Share: $1.08
GF Value™: $49.17 vs. price of $20.83 (57.6% below fair value)
Industry Position: 90.8% below the Healthcare Providers & Services median (#182 of 532)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score
Get the complete analysis for DOCS
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
